Advertisement

Abdominal Radiology

, Volume 42, Issue 3, pp 851–860 | Cite as

MDCT assessment of resectability in hilar cholangiocarcinoma

  • Qihong Ni
  • Haolu Wang
  • Yunhe Zhang
  • Lijun Qian
  • Jiachang Chi
  • Xiaowen Liang
  • Tao Chen
  • Jian WangEmail author
Article

Abstract

Purpose

The purpose of this study is to investigate the value of multidetector computed tomography (MDCT) assessment of resectability in hilar cholangiocarcinoma, and to identify the factors associated with unresectability and accurate evaluation of resectability.

Methods

From January 2007 to June 2015, a total of 77 consecutive patients were included. All patients had preoperative MDCT (with MPR and MinIP) and surgical treatment, and were pathologically proven with hilar cholangiocarcinoma. The MDCT images were reviewed retrospectively by two senior radiologists and one hepatobiliary surgeon. The surgical findings and pathologic results were considered to be the gold standard. The Chi square test was used to identify factors associated with unresectability and accurate evaluation of resectability.

Results

The sensitivity, specificity, and overall accuracy of MDCT assessment were 83.3 %, 75.9 %, and 80.5 %, respectively. The main causes of inaccuracy were incorrect evaluation of N2 lymph node metastasis (4/15) and distant metastasis (4/15). Bismuth type IV tumor, main or bilateral hepatic artery involvement, and main or bilateral portal vein involvement were highly associated with unresectability (P < 0.001). Patients without biliary drainage had higher accuracy of MDCT evaluation of resectability compared to those with biliary drainage (P < 0.001).

Conclusion

MDCT is reliable for preoperative assessment of resectability in hilar cholangiocarcinoma. Bismuth type IV tumor and main or bilateral vascular involvement highly suggest the unresectability of hilar cholangiocarcinoma. Patients without biliary drainage have a more accurate MDCT evaluation of resectability. We suggest MDCT should be performed before biliary drainage to achieve an accurate evaluation of resectability in hilar cholangiocarcinoma.

Keywords

Hilar cholangiocarcinoma MDCT Preoperative evaluation Resectability 

Notes

Acknowledgments

Dr. Haolu Wang acknowledges Shanghai Young Teachers’ Development Program (ZZjdyx12070). The authors thank Dr. Guozhen Zhang, the former radiologist-in-chief in the Department of Radiology at Huadong Hospital, Shanghai, China, for his long-term support and consideration.

Compliance with ethical standards

Funding

This work was supported by grants from National Key Technology R&D Program (2012BAI06B01), Shanghai Science and Technology Commission (10411955400 and 12XD1403400) and Shanghai Bureau of the Health (XBR2011035).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was waived by the ethics committee of the institutional review board.

References

  1. 1.
    Aljiffry M, Walsh MJ, Molinari M (2009) Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 15:4240–4262CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Deoliveira ML, Schulick RD, Nimura Y, et al. (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53:1363–1371. doi: 10.1002/hep.24227 CrossRefPubMedGoogle Scholar
  3. 3.
    Matsuo K, Rocha FG, Ito K, et al. (2012) The blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 215:343–355. doi: 10.1016/j.jamcollsurg.2012.05.025 CrossRefPubMedGoogle Scholar
  4. 4.
    Wu XS, Dong P, Gu J, et al. (2013) Combined portal vein resection for hilar cholangiocarcinoma: a meta-analysis of comparative studies. J Gastrointest Surg 17:1107–1115. doi: 10.1007/s11605-013-2202-9 CrossRefPubMedGoogle Scholar
  5. 5.
    Hidalgo E, Asthana S, Nishio H, et al. (2008) Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol 34:787–794. doi: 10.1016/j.ejso.2007.10.005 CrossRefPubMedGoogle Scholar
  6. 6.
    Marsh RW, Alonzo M, Bajaj S, et al. (2012) Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. J Surg Oncol 106:339–345. doi: 10.1002/jso.23027 CrossRefGoogle Scholar
  7. 7.
    Wang H, Wang H, Chen T, et al. (2014) Evaluation of the POSSUM, P-POSSUM and E-PASS scores in the surgical treatment of hilar cholangiocarcinoma. World J Surg Oncol 12:191. doi: 10.1186/1477-7819-12-191 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Choi JY, Kim MJ, Lee JM, et al. (2008) Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol 191:1448–1457. doi: 10.2214/AJR.07.3992 CrossRefPubMedGoogle Scholar
  9. 9.
    Ruys AT, Van Beem BE, Engelbrecht MR, et al. (2012) Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol 85:1255–1262. doi: 10.1259/bjr/88405305 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Unno M, Okumoto T, Katayose Y, et al. (2007) Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 14:434–440. doi: 10.1007/s00534-006-1191-4 CrossRefPubMedGoogle Scholar
  11. 11.
    Kim MJ, Choi JY, Chung YE (2010) Evaluation of biliary malignancies using multidetector-row computed tomography. J Comput Assist Tomogr 34:496–505. doi: 10.1097/RCT.0b013e3181d34532 CrossRefPubMedGoogle Scholar
  12. 12.
    Chen HW, Lai EC, Pan AZ, et al. (2009) Preoperative assessment and staging of hilar cholangiocarcinoma with 16-multidetector computed tomography cholangiography and angiography. Hepatogastroenterology 56:578–583PubMedGoogle Scholar
  13. 13.
    Stockberger SM, Wass JL, Sherman S, Lehman GA, Kopecky KK (1994) Intravenous cholangiography with helical CT: comparison with endoscopic retrograde cholangiography. Radiology 192:675–680. doi: 10.1148/radiology.192.3.8058932 CrossRefPubMedGoogle Scholar
  14. 14.
    Han JK, Choi BI, Kim AY, et al. (2002) Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 22:173–187CrossRefPubMedGoogle Scholar
  15. 15.
    Park HS, Lee JM, Choi JY, et al. (2008) Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol 190:396–405. doi: 10.2214/AJR.07.2310 CrossRefPubMedGoogle Scholar
  16. 16.
    Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 168:1439–1443. doi: 10.2214/ajr.168.6.9168704 CrossRefPubMedGoogle Scholar
  17. 17.
    Lee HY, Kim SH, Lee JM, et al. (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239:113–121. doi: 10.1148/radiol.2383050419 CrossRefPubMedGoogle Scholar
  18. 18.
    Masselli G, Manfredi R, Vecchioli A, Gualdi G (2008) MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol 18:2213–2221. doi: 10.1007/s00330-008-1004-z CrossRefPubMedGoogle Scholar
  19. 19.
    Razumilava N, Gores GJ (2014) Cholangiocarcinoma. Lancet 383:2168–2179. doi: 10.1016/S0140-6736(13)61903-0 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Aloia TA, Charnsangavej C, Faria S, et al. (2007) High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193:702–706. doi: 10.1016/j.amjsurg.2006.10.024 CrossRefPubMedGoogle Scholar
  21. 21.
    Denecke T, Degutyte E, Stelter L, et al. (2006) Minimum intensity projections of the biliary system using 16-channel multidetector computed tomography in patients with biliary obstruction: comparison with MRCP. Eur Radiol 16:1719–1726. doi: 10.1007/s00330-006-0172-y CrossRefPubMedGoogle Scholar
  22. 22.
    Li J, Kuehl H, Grabellus F, et al. (2008) Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT. J Surg Oncol 98:438–443. doi: 10.1002/jso.21136 CrossRefPubMedGoogle Scholar
  23. 23.
    Imai H, Doi R, Kanazawa H, et al. (2010) Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer. Int J Clin Oncol 15:294–300. doi: 10.1007/s10147-010-0066-5 CrossRefPubMedGoogle Scholar
  24. 24.
    Barlow AD, Garcea G, Berry DP, et al. (2013) Staging laparoscopy for hilar cholangiocarcinoma in 100 patients. Langenbecks Arch Surg 398:983–988. doi: 10.1007/s00423-013-1104-3 CrossRefPubMedGoogle Scholar
  25. 25.
    Abbas S, Sandroussi C (2013) Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 15:492–503. doi: 10.1111/j.1477-2574.2012.00616.x CrossRefGoogle Scholar
  26. 26.
    Chen W, Ke K, Chen YL (2014) Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol 40:489–495. doi: 10.1016/j.ejso.2014.02.231 CrossRefPubMedGoogle Scholar
  27. 27.
    Ebata T, Nagino M, Kamiya J, et al. (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238:720–727. doi: 10.1097/01.sla.0000094437.68038.a3 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Qihong Ni
    • 1
  • Haolu Wang
    • 1
    • 2
  • Yunhe Zhang
    • 1
  • Lijun Qian
    • 3
  • Jiachang Chi
    • 3
  • Xiaowen Liang
    • 2
  • Tao Chen
    • 1
  • Jian Wang
    • 1
    Email author
  1. 1.Department of Biliary-pancreatic Surgery, School of Medicine, Ren Ji HospitalShanghai Jiao Tong UniversityShanghaiChina
  2. 2.Therapeutics Research Centre, School of Medicine, Princess Alexandra HospitalThe University of QueenslandBrisbaneAustralia
  3. 3.Department of Radiology, School of Medicine, Ren Ji HospitalShanghai Jiao Tong UniversityShanghaiChina

Personalised recommendations